A recent prospective observational study, evaluating IFN-α levels in a cohort of hospitalized COVID-19 patients with respiratory failure highlighted that increases in blood IFN-α levels were directly associated with improvement in COVID-19 disease severity and greater survival (11). This evidence concerns the gene IFNA1 and COVID-19.